Bone Cement & Glue Market Size, Share, Growth and Forecast (2026 - 2036)

Bone Cement & Glue Market Forecast and Outlook By FactMR

• The bone cement & glue market was valued at USD 1.6 billion in 2025.
• According to Fact.MR, demand is projected to reach USD 1.7 billion in 2026 and expand to USD 3.0 billion by 2036, reflecting a CAGR of 6.1% during the forecast period.

Summary of Bone Cement & Glue Market

• Market Definition
  • The market includes bone cement and bone glue used for implant fixation, bone repair, spinal stabilization, and orthopedic bonding during surgical procedures.
• Demand Drivers
  • Orthopedic surgeons are using bone cement in joint replacement where implant fixation must remain stable under load-bearing conditions.
  • Spine surgeons need cementing materials for vertebral augmentation procedures where weakened vertebrae require internal support.
  • Trauma care facilities use fixation materials where fracture repair requires fast stabilization and surgical workflow reliability.
• Key Segments Analyzed
  • By Type: Bone cement is expected to hold approximately 60.0% share in 2026, supported by arthroplasty and implant fixation use.
  • By Material: Polymethyl methacrylate cement leads in 2026 with about 48.0% share, due to long clinical use in joint replacement.
  • By Application: Arthroplasty accounts for around 46.0% share in 2026, driven by knee and hip replacement procedures.
  • By End User: Hospitals hold nearly 58.0% share in 2026, since complex orthopedic and spinal surgeries need advanced infrastructure.
  • By Sales Channel: Direct institutional sales are projected to lead with 43.0% share in 2026, as hospitals prefer supplier contracts and clinical support.
  • By Geography: China leads growth through 2036 at 9.2% CAGR, supported by hospital expansion and orthopedic procedure access.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, notes, “Bone cement and glue demand is no longer tied only to more orthopedic procedures. The stronger shift is toward fixation reliability, controlled handling, and infection-risk management. Suppliers that can prove clinical consistency, surgeon support, and material safety will hold a better position than companies competing only on availability.”
• Strategic Implications
  • Manufacturers should improve handling consistency because surgeons evaluate cement and glue through curing behavior and procedural control.
  • Hospitals need qualified supplier relationships to reduce variability in implant fixation and spinal repair procedures.
  • Distributors should prioritize surgeon education and inventory reliability, since procedure delays can affect orthopedic operating schedules.
• Methodology
  • Market sizing uses orthopedic procedure demand, spinal augmentation use, cemented fixation rates, and formulation-level pricing.
  • Analysis includes FDA guidance, ISO standards, orthopedic society resources, product catalogues, and supplier information.
  • Forecasts account for aging populations, joint replacement growth, trauma repair needs, spinal fracture treatment, and hospital purchasing cycles.

The market is expected to generate an absolute opportunity of USD 1.3 billion between 2026 and 2036, supported by steady procedural demand. Growth is being driven by arthroplasty procedures, spinal fracture repair, trauma cases, and the continued use of cemented fixation in orthopedic implants. Regulatory oversight from the U.S. Food and Drug Administration emphasizes postmarket monitoring for implanted materials that influence patient outcomes, while ISO 10993 standards reinforce the importance of biological evaluation for materials in contact with bone and tissue. These requirements ensure that safety, performance, and long-term compatibility remain central to supplier positioning. [1]

China leads with a projected CAGR of 9.2% through 2036, supported by hospital expansion and rising orthopedic procedure access. India follows at 8.4%, helped by trauma care demand and wider private orthopedic capacity. The United States records 6.4%, with demand anchored in joint replacement and spinal care. Germany grows at 5.8%, supported by structured orthopedic care and hospital purchasing discipline. Brazil posts 5.6%, backed by private hospital investment and trauma repair needs. Japan advances at 3.4%, supported by aging-related orthopedic procedures and steady hospital demand.

Segmental Analysis

Bone Cement & Glue Market Analysis by Type

Bone cement is expected to hold 60.0% share in 2026 because it remains central to implant fixation and vertebral repair. Hospitals and orthopedic surgeons prefer cement in procedures where immediate mechanical stability is needed. Joint replacement, trauma repair, and vertebral augmentation continue to create repeated demand for cement-based fixation. AAOS resources describe joint replacement as a key orthopedic treatment for damaged joints, which supports the large clinical base for cement use [6]. Bone glue has a narrower but growing role in selected repair and bonding applications. Facilities that use unsuitable fixation materials can face loosening risk, longer recovery pathways, and higher revision concerns.

• Implant Fixation: Bone cement fills the gap between implant and bone during selected joint replacement procedures.
• Procedure Control: Surgeons value predictable working time and curing behavior during cement application.
• Revision Risk: Stable fixation helps reduce avoidable follow-up procedures linked to poor implant seating.

Bone Cement & Glue Market Analysis by Material

Mechanical reliability and surgeon familiarity keep polymethyl methacrylate cement ahead in material selection. It is projected to account for 48.0% share in 2026. PMMA cement is widely used in arthroplasty because it provides durable fixation and has a long clinical record. ISO 10993 biological evaluation standards reinforce the need to assess safety when medical materials contact tissue and bone. Calcium phosphate cement gains use where bone-like mineral composition is valued, while antibiotic-loaded cement is important in infection-risk procedures. PMMA keeps the largest base because hospitals and surgeons understand its handling. Poor material selection can affect fixation quality and raise the need for corrective surgery.

• Fixation Strength: PMMA cement provides stable mechanical support in selected joint replacement procedures.
• Handling Familiarity: Surgeons often prefer materials with known mixing, working, and curing profiles.
• Infection Control: Antibiotic-loaded variants add value where revision or infection risk is a concern.

Bone Cement & Glue Market Analysis by Application

Arthroplasty remains the largest application because knee and hip replacement procedures depend on reliable implant fixation. This application is estimated to account for 46.0% share in 2026. Orthopedic surgeons use bone cement where cemented fixation is preferred for patient anatomy, bone quality, or implant design. AAOS describes total joint replacement as a common approach for damaged joints, which supports continued cement demand in orthopedic care. Kyphoplasty and vertebroplasty grow through spinal fracture treatment, but arthroplasty retains the largest base because procedure volume is broader. Hospitals that do not maintain reliable cement supply may face disruptions in planned joint replacement schedules.

• Joint Replacement: Arthroplasty creates recurring cement demand across hip and knee procedures.
• Surgical Scheduling: Hospitals need dependable supply because planned replacement procedures are volume-sensitive.
• Bone Quality: Cemented fixation remains useful where bone condition affects implant stability.

Bone Cement & Glue Market Analysis by End User

Hospitals lead demand because orthopedic, spinal, and trauma procedures require operating rooms, imaging support, sterilization systems, and specialist surgeons. The end-user base is expected to be led by hospitals with 58.0% share in 2026. Hospitals handle complex arthroplasty and vertebral repair cases that need trained surgical staff and emergency backup. CMS information on ambulatory surgical centers shows the growing role of outpatient procedure environments, but higher-complexity orthopedic work still depends heavily on hospitals [5]. Clinics and ambulatory centers serve selected procedures, yet hospitals retain the largest demand base. Weak supply coordination can delay operating schedules and affect patient flow.

• Surgical Infrastructure: Hospitals provide the operating room and imaging setup needed for complex bone repair.
• Specialist Access: Orthopedic and spine procedures often require trained surgeons and anesthesia support.
• Inventory Control: Hospital supply departments need consistent cement availability for scheduled procedures.

Bone Cement & Glue Market Analysis by Sales Channel

Large healthcare facilities prefer direct supplier engagement because bone cement and glue purchases require product qualification, traceability, and training support. Direct institutional sales are expected to account for 43.0% share in 2026. This channel leads where hospitals negotiate recurring supply agreements and require documentation for implantable materials. Distributor sales remain important for clinics, dental surgical centers, and smaller orthopedic facilities. FDA medical device reporting guidance highlights the importance of postmarket monitoring, which makes supplier traceability important for materials used in procedures. Low-support channels can create risk when surgeons need formulation-specific handling guidance.

• Contract Reliability: Direct sales help hospitals secure recurring supply for scheduled orthopedic procedures.
• Documentation Needs: Implant-related materials require traceability from supplier to clinical use.
• Surgeon Support: Supplier training helps surgical staff manage mixing, application, and curing behavior.

Drivers, Restraints, and Opportunities

Aging populations, joint degeneration, osteoporosis, and trauma injuries are increasing the need for orthopedic repair materials. Bone cement and glue help surgeons stabilize implants, fill voids, and support repair during joint and spinal procedures. CDC aging resources show how older populations create greater pressure on musculoskeletal care and long-term mobility needs [3]. Demand improves where hospitals can combine trained surgeons, reliable supply, and safe material handling. Suppliers are being evaluated through material performance, infection management, and clinical documentation rather than simple product availability.

Cost pressure and clinical risk restrain faster growth. New bone cement and glue formulations require safety evidence, biocompatibility testing, and surgeon confidence before wider adoption. Reimbursement gaps in several countries can limit use of premium materials. Cement-related complications, implant loosening, and infection concerns can affect surgeon preference. Hospitals may delay switching brands when clinical teams are already comfortable with existing products. Suppliers must prove consistent handling and long-term performance before gaining share in complex orthopedic procedures.

• Antibiotic-Loaded Cement: Infection-risk procedures create demand for cement formulations that support surgical infection management.
• Spinal Repair Growth: Kyphoplasty and vertebroplasty create opportunities where aging patients need vertebral stabilization.
• Dental Bone Repair: Dental surgical centers can expand glue and cement use where implant-related bone repair requires bonding support.

Regional Analysis

The bone cement & glue market is assessed across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, covering 40+ countries with demand profiles shaped by orthopedic procedure access, hospital capability, trauma care, surgeon availability, and reimbursement systems.

Source: Fact.MR analysis, based on proprietary forecasting model and primary research

Asia Pacific Bone Cement & Glue Market Analysis

Asia Pacific records the strongest growth because orthopedic access, hospital investment, and trauma repair demand are rising together. China and India are expanding procedure capacity across urban healthcare systems. Japan adds a more stable demand base through aging-related joint and spinal care. Product quality systems such as ISO 13485 support structured medical device manufacturing and supplier qualification across global supply chains. The region contains premium hospitals and price-sensitive facilities. Suppliers need differentiated portfolios that address both affordability and clinical reliability. Growth depends on surgeon training, implant procedure access, and hospital purchasing capacity.

• China: China leads the country outlook as hospital expansion and orthopedic procedure access strengthen demand for cemented fixation. The country is projected to grow at 9.2% CAGR by 2036. Joint replacement and spinal repair needs are increasing across urban hospitals. Domestic suppliers compete in standard formulations, while premium products gain traction in advanced surgical centers. Surgeons weigh working time, fixation strength, and infection-risk features before product selection.
• India: Trauma care demand and rising private orthopedic capacity support bone cement & glue adoption in India. Hospitals in metro and tier-one cities are expanding joint replacement and spinal repair procedures. India is forecast to grow at 8.4% CAGR over the assessment period. Price sensitivity remains important, but surgeons still prefer reliable materials in complex cases. Suppliers that combine accessible pricing with surgeon support can improve adoption.
• Japan: Aging-related joint degeneration and spinal fracture care keep Japan relevant for bone cement & glue demand. Hospitals focus on reliable materials that help reduce revision concerns. Japan is projected to post 3.4% CAGR through 2036. Growth is moderate because procedure access is already established. Suppliers with stable clinical performance and strong surgeon relationships can maintain demand in planned orthopedic care.

North America Bone Cement & Glue Market Analysis

North America remains a high-value region because advanced orthopedic infrastructure and strong surgeon specialization support cemented fixation and spinal repair procedures. The United States anchors demand through joint replacement, trauma repair, and vertebral augmentation procedures. FDA medical device oversight keeps safety documentation and postmarket performance central to supplier access. Hospitals often evaluate bone cement through handling behavior, infection control, and surgeon preference. The region has premium demand, but healthcare cost control creates pressure on product pricing. Suppliers must defend value through consistent clinical performance and procedural efficiency.

• USA: The United States has a large orthopedic procedure base across joint replacement, spinal repair, and trauma surgery. Hospitals use bone cement and glue where fixation strength and procedural predictability are important. The country is projected to record 6.4% CAGR from 2026 to 2036. Supplier selection depends on clinical documentation, surgeon familiarity, and reliable inventory support. Premium formulations gain attention where infection risk and revision concerns influence product choice.

Europe Bone Cement & Glue Market Analysis

Europe shows steady demand because orthopedic care pathways, medical device regulation, and hospital purchasing systems are well structured. Germany leads the region through strong orthopedic infrastructure and surgeon familiarity with cemented procedures. The European Commission states that the EU medical device framework focuses on patient safety and device performance, which shapes product evaluation for implant-related materials [2]. Hospitals emphasize documentation, quality systems, and postmarket surveillance. Demand growth is moderate because many markets already have established procedure access. Suppliers compete through clinical proof, handling consistency, and infection-management options.

• Germany: Germany benefits from advanced orthopedic care and structured hospital purchasing. Demand is linked to arthroplasty, vertebral repair, and trauma procedures. Germany is forecast to grow at 5.8% CAGR by 2036. Hospitals tend to favor suppliers with regulatory strength and proven long-term material performance. Surgeon confidence and technical support influence purchasing more than broad catalogue availability.

Latin America Bone Cement & Glue Market Analysis

Latin America shows selective growth where private hospitals and orthopedic centers are expanding surgical access. Brazil leads regional demand through trauma repair, joint replacement, and private healthcare investment. Price sensitivity remains a key restraint, especially for premium antibiotic-loaded and specialty formulations. Suppliers need strong distributor support and practical pricing models. Growth improves when hospitals can maintain steady inventories and surgeons gain confidence in product handling. Demand remains uneven because public healthcare budgets and reimbursement conditions differ across countries.

• Brazil: Private hospitals and orthopedic centers support bone cement & glue demand in Brazil. Trauma repair and joint replacement are important demand areas in urban healthcare centers. Brazil is projected to expand at 5.6% CAGR over the forecast period. Hospitals often compare affordability with clinical reliability before selecting cement brands. Distributors play a major role in product availability, training support, and replacement supply. Suppliers that offer consistent formulations at accessible price points can strengthen adoption.

Fact.MR analysis of regional demand covers Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. The study assesses orthopedic infrastructure, surgeon access, trauma care needs, reimbursement conditions, and supplier support across major markets.

Competitive Aligners for Market Players

The bone cement & glue market is moderately concentrated in advanced formulations and more fragmented in standard cement products. Large global suppliers hold advantages because regulatory documentation, surgeon familiarity, and hospital contracts create switching barriers. Smaller suppliers often compete in standard PMMA cement, selected dental applications, and region-specific supply channels.

Competitive advantage depends on formulation consistency, curing behavior, antibiotic-loading capability, and surgeon support. Heraeus Medical, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew, and Teknimed represent supplier groups where orthopedic product depth and hospital access matter. Hospitals are less likely to switch suppliers when surgical teams are trained on a specific cement system.

The market is divided between high-volume standard bone cement and specialty products used in infection-risk, spinal, and dental procedures. Suppliers that combine reliable product performance with training and documentation can protect institutional demand. Regional companies can gain ground where affordability and distributor access are more important.

Key Players

• Exactech, Inc.
• Teknimed
• Arthrex, Inc.
• CryoLife, Inc.
• Stryker Corporation
• DJO Global, Inc.
• Heraeus Medical LLC
• Cardinal Health, Inc.
• Smith & Nephew PLC
• DePuy Synthes
• Trimph Pty Ltd
• Zimmer Biomet Holdings, Inc.

Bibliography

• [1] United States Food and Drug Administration. (2025, March 27). Medical Device Reporting (MDR): How to Report Medical Device Problems. FDA.
• [2] European Commission. (2024). Medical Devices Sector. European Commission.
• [3] Centers for Disease Control and Prevention. (2024, May 14). Aging and Health. CDC.
• [4] International Organization for Standardization. (2024). ISO 10993 Biological Evaluation of Medical Devices. ISO.
• [5] Centers for Medicare & Medicaid Services. (2024). Ambulatory Surgical Centers. CMS.
• [6] American Academy of Orthopaedic Surgeons. (2024). Total Joint Replacement. OrthoInfo.

This Report Addresses

• Strategic intelligence on bone cement & glue demand across arthroplasty, vertebral augmentation, trauma repair, and dental bone repair globally.
• Market forecast from USD 1.7 billion in 2026 to USD 3.0 billion by 2036 at a CAGR of 6.1%.
• Growth opportunity mapping across China hospital expansion, India trauma care demand, U.S. joint replacement volume, Germany orthopedic care, and Brazil private hospital investment.
• Segment analysis by type, material, application, end user, sales channel, and region.
• Regional outlook covering Asia Pacific orthopedic access, North America premium procedure demand, and Europe regulatory-controlled product evaluation.
• Competitive analysis of Exactech, Teknimed, Arthrex, Stryker, Heraeus Medical, Cardinal Health, Smith & Nephew, DePuy Synthes, and Zimmer Biomet.
• Device adoption analysis covering fixation strength, curing behavior, material safety, infection risk, and surgeon training.
• Report delivered with market sizing, segment outlook, regional analysis, company profiling, and forecast assumptions.

Bone Cement & Glue Market Definition

The market covers bone cement and bone glue used to fix, seal, bond, or stabilize bone structures during orthopedic, spinal, trauma, and dental procedures. These materials are used in joint replacement, vertebral augmentation, fracture repair, and implant fixation. The scope includes synthetic and natural formulations supplied for clinical use in hospitals, specialty centers, and surgical facilities.

Bone Cement & Glue Market Inclusions

The study includes global and regional forecasts from 2026 to 2036. It covers polymethyl methacrylate cement, calcium phosphate cement, glass polyalkenoate cement, antibiotic-loaded bone cement, non-antibiotic bone cement, natural bone glue, and synthetic bone glue. It includes use across arthroplasty, kyphoplasty, vertebroplasty, trauma repair, and dental bone repair.

Bone Cement & Glue Market Exclusions

The scope excludes bone graft substitutes when used without adhesive or cementing function. It also excludes external orthopedic braces, plates, screws, surgical drills, and general wound adhesives used outside bone repair. The focus stays on materials that directly support fixation, sealing, or bonding within bone-related procedures.

Bone Cement & Glue Market Research Methodology

• Primary Research
  • Interviews with orthopedic surgeons, spine surgeons, hospital purchasing heads, trauma care specialists, dental implant surgeons, and medical device distributors across major consuming regions.
• Desk Research
  • Uses medical device regulatory guidance, orthopedic procedure references, company product catalogues, biomaterial standards, and clinical safety documentation. [4]
• Market-Sizing and Forecasting
  • Hybrid model using joint replacement volumes, spinal repair procedures, cemented implant use, trauma repair demand, and average selling prices by formulation.
• Data Validation and Update Cycle
  • Forecasts were validated through supplier channel checks, hospital purchasing patterns, product availability, regulatory references, and surgeon preference inputs.